Uganda has gotten plenty of kudos and some criticism over its roll out of the new antiretroviral therapy for pregnant women and their babies, known as Option B +.
Seventeen-year-old Natalie Mlambo* has two good reasons to get tested for HIV. She has two boyfriends and has unprotected sex with them. One is a high school classmate. The other is older, works in a bank, and can afford to give Mlambo small gifts and some money.
At the Cocody-Anono community health centre, south-east of the Ivorian economic capital of Abidjan, Bertine Bahi* regularly attends awareness sessions on Preventing Mother-to-Child Transmission (PMTCT) for women living with HIV.
With a wide smile Beatrice M.* says that she lives by the motto “life is short and beautiful — live it to the full.” The 20-year-old, HIV-positive mother refuses to be defeated by her new circumstances.
“If I don’t have my pills, I don’t know what will happen. I will probably get sick again, very sick. Maybe I will die this time,” says Xoliswa Mbana* as she readies her four young children for school in the impoverished informal settlement of Masiphumelele, in Cape Town, South Africa.
U.N. agency heads gathered Tuesday to reassert their unified commitment to ending the epidemic of violence against women and girls, and bringing justice and healing to survivors.
While India has drastically reduced the spread of HIV over the past decade, new strains of the virus that cause acquired immunodeficiency syndrome (AIDS) are troubling medical scientists in this country.
India may be famous for the Taj Mahal, its religious ceremonies, Bollywood films and one of the highest economic growth rates in recent years. But more importantly, India has had a positive global impact through its supply of vast quantities of low-cost, good-quality generic medicines, which have saved or prolonged millions of lives.